Related Experiment Video
Updated: May 22, 2026

07:03
Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
EMT in breast cancer stem cell generation.
1INSERM UMR 1052, Lyon, France. stephane.ansieau@lyon.fnclcc.fr
Cancer Letters
|May 29, 2012
Summary
Cancer stem cells (CSCs) may originate from differentiated cells via epithelial to mesenchymal transition (EMT), a process that could explain tumor heterogeneity. This study revisits EMT
Area of Science:
- Oncology
- Cell Biology
- Developmental Biology
Background:
- The cancer stem cell (CSC) hypothesis explains tumor heterogeneity and recurrence.
- The origin of CSCs is debated, with proposed mechanisms including stem/progenitor transformation or dedifferentiation of cancer cells.
- Epithelial to mesenchymal transition (EMT) is a developmental process implicated in cancer progression.
Purpose of the Study:
- To revisit the role of EMT in generating CSCs.
- To explore the mechanisms and biological significance of EMT in CSC formation.
- To investigate CSC origin using breast carcinomas as a model system.
Main Methods:
- Review and analysis of existing literature on CSCs and EMT.
- Comparative study of breast carcinoma models.
- Exploration of potential molecular mechanisms linking EMT and CSCs.
Main Results:
- EMT presents a viable alternative or complementary mechanism for CSC generation.
- EMT can induce stem-like properties in differentiated cancer cells.
- Understanding EMT's role is crucial for targeting CSCs and improving cancer therapy.
Conclusions:
- EMT is a significant contributor to CSC generation and tumor heterogeneity.
- Targeting EMT pathways may offer novel therapeutic strategies against CSCs.
- Further research is needed to fully elucidate the interplay between EMT and CSCs in various cancer types.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

